Introduction Interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), represents a group of chronic, progressive lung disorders characterized by inflammation and scarring of lung tissue. Since the rollout of…[...]
Read More
While COVID-19 vaccines have played a pivotal role in reducing severe disease and death, a small number of peer-reviewed studies have documented serious pulmonary complications—particularly interstitial lung disease (ILD)—following vaccination.…[...]
Read More
Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), continues to affect millions globally, with shortness of breath and impaired gas exchange among its most persistent symptoms. Recent peer-reviewed studies…[...]
Read More
Nicolas Bakinde • Antoinette Johnson • Deborah Ngo Bakinde • Priscilla Pemu • Eric Flenaugh, DOI: 10.7759/cureus.86412 Abstract Systemic sclerosis-associated interstitial lung disease (ILD) is a major contributor to morbidity and mortality in patients with diffuse systemic sclerosis. We…[...]
Read More
DEC 14, 2023 - Authored by Amie Dahnke via The Epoch Times The COVID-19 virus can remain in the lungs for months after an individual has been infected—even though it…[...]
Read More
Author: Christopher Vaughan, Stanford Medicine 2023 Stanford Medicine researchers have found a mechanism behind one of the most common symptoms of long COVID -- shortness of breath. Post COVID-19 breathing…[...]
Read More
James May, Jane A. Mitchell, and R. Gisli Jenkins, Published September 15, 2023 - 10.1172/JCI172058 Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor survival. The incidence and…[...]
Read More
Authors: Peng Pi1† Zhipeng Zeng1† Liqing Zeng1 Bing Han1 Xizhe Bai2 Shousheng Xu3*Front. Pharmacol., 03 August 2023, Sec. Respiratory Pharmacology, Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1218059 As the outbreak of COVID-19 caused by severe acute respiratory…[...]
Read More
Marlies Wijsenbeek, M.D., and Vincent Cottin, M.D. New England Journal of Medicine 2023 Diffuse parenchymal lung diseases encompass a large number of conditions, with a wide range of causes, clinical…[...]
Read More
Mark Barash, DOa,∗ and Vijaya Ramalingam, MD, FCCPa,b Clin Chest Med. 2023 Jun; 44(2): 263–277. Published online 2023 Mar 3. doi: 10.1016/j.ccm.2022.11.019 PMCID: PMC9983785 PMID: 37085219 Author information Copyright and License information PMC Disclaimer As the world emerges from…[...]
Read More